Clinical implications of recurring chromosomal and associated molecular abnormalities in acute lymphoblastic leukemia

Seminars in Hematology

Volumn 37, Issue 4, 2000, Pages 381-395

  Ferrando, Adolfo A ^a   Look, A Thomas ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMETABOLITE; ASPARAGINASE; IMATINIB; PROTEIN TYROSINE KINASE INHIBITOR;

ACUTE LYMPHOBLASTIC LEUKEMIA; BLAST CELL; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER REGRESSION; CANCER RISK; CELL COUNT; CHROMOSOME ABERRATION; CONFERENCE PAPER; DISEASE ASSOCIATION; DRUG ACTIVITY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOPHENOTYPING; KARYOTYPE; ONSET AGE; PRIORITY JOURNAL; PROGNOSIS;

EID: 0033788513     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0037-1963(00)90018-0     Document Type: Conference Paper

References (131)

1. Cytogenetic abnormalities in adult acute lymphoblastic leukemia: Correlations with hematologic findings outcome. A Collaborative Study of the Group Francais de Cytogenetique Hematologique
2. Childhood acute lymphoblastic leukemia: Is there a tumor suppressor gene in chromosome 12p12.3?
3. Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia
4. TEL-AML1 fusion transcript designates a favorable outcome with an intensified protocol in childhood acute lymphoblastic leukemia
5. TAL1, TAL2, and LYL1: A family of basic helix-loop-helix proteins implicated in T cell acute leukemia
6. Transcription factors of the bHLH and LIM families: Synergistic mediators of T cell acute leukemia?
7. Clinical features and outcome of T-cell acute lymphoblastic leukemia in childhood with respect to alterations at the TAL1 locus: A Pediatric Oncology Group study
8. Does activation of the TAL1 gene occur in a majority of patients with T-cell acute lymphoblastic leukemia? A Pediatric Oncology Group study
9. The SCL gene: From case report to critical hematopoietic regulator
10. Rearrangement of the MLL gene confers a poor prognosis in childhood acute lymphoblastic leukemia, regardless of presenting age
11. Dicentric (9;12) in acute lymphocytic leukemia and other hematological malignancies: Report from a dic(9;112) study group
12. Reduced folate carrier expression in acute lymphoblastic leukemia: A mechanism for ploidy but not lineage differences in methotrexate accumulation
13. Six-year follow-up of the clinical significance of karyotype in acute lymphoblastic leukemia
14. Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials
15. Multiple negative elements contribute to repression of the HOX11 proto-oncogene
16. Identification and molecular characterization of CALM/AF10 fusion products in T cell acute lymphoblastic leukemia and acute myeloid leukemia
17. Cytogenetics and prognosis in childhood lymphoblastic leukaemia: Results of MRC UKALL X
18. Lymphoblastic leukemia with lymphomatous features associated with abnormalities of the short arm of chromosome 9
19. Acute lymphoblastic leukemia
20. Philadelphia chromosome positive childhood acute lymphoblastic leukemia: Clinical and cytogenetic characteristics and treatment outcome. A Pediatric Oncology Group study
21. Poor prognosis of children with pre-B acute lymphoblastic leukemia is associated with the t(1;19)(q23;p13): A Pediatric Oncology Group study
22. MLL rearrangements in haematological malignancies: Lessons from clinical and biological studies
23. Tumorigenesis in mice with a fusion of the leukaemia oncogene mll and the bacterial lacZ gene
24. Critical study of prognostic factors in childhood acute lymphoblastic leukaemia: Differences in outcome are poorly explained by the most significant prognostic variables. French Acute Lymphoblastic Leukaemia study group
25. The AML1-ETO chimaeric transcription factor in acute myeloid leukaemia: Biology and clinical significance
26. Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells
27. The t(10;11)(p13;q14) in the U937 cell line results in the fusion of the AF10 gene and CALM, encoding a new member of the AP- 3 clathrin assembly protein family
28. MLL and CALM are fused to AF10 in morphologically distinct subsets of acute leukemia with translocation t(10;11): Both rearrangements are associated with a poor prognosis
29. Clinical significance of cytogenetic abnormalities in adult acute lymphoblastic leukemia
30. Outcome of Philadelphia chromosome-positive adult acute lymphoblastic leukemia
31. Cytogenetics and their prognostic value in childhood and adult acute lymphoblastic leukemia (ALL) exduding L3
32. A common mechanism of chromosomal translocation in T- and B-cell neoplasia
33. The MYC dualism in growth and death
34. The TEL gene contributes to the pathogenesis of myeloid and lymphoid leukemias by diverse molecular genetic mechanisms
35. Biological consequences of the BCR/ABL fusion gene in humans and mice
36. The t(5;14) chromosomal translocation in a case of acute lymphocytic leukemia joins the interleukin-3 gene to the immunoglobulin heavy chain gene
37. T cell leukemia-associated human Notch/translocation-associated Notch homologue has I kappa B-like activity and physically interacts with nuclear factor-kappa B proteins in T cells
38. Trisomy of leukemic cell chromosomes 4 and 10 identifies children with B-progenitor cell acute lymphoblastic leukemia with a very low risk of treatment failure: A Pediatric Oncology Group study
39. The HOX11 homeobox-containing gene of human leukemia immortalizes murine hematopoietic precursors
40. Abnormalities of the long arm of chromosome 6 in childhood acute lymphoblastic leukemia
41. Hypodiploidy with less than 45 chromosomes confers adverse risk in childhood acute lymphoblastic leukemia: A report from the Children's Cancer Group
42. Frequency and clinical significance of cytogenetic abnormalities in pediatric T-lineage acute lymphoblastic leukemia: A report from the Children's Cancer Group
43. Association of chromosome arm 9p abnormalities with adverse risk in childhood acute lymphoblastic leukemia: A report from the Children's Cancer Group
44. Prognostic importance of p15INK4B and p16INK4 gene inactivation in childhood acute lymphocytic leukemia
45. Improved outcome in adult B-cell acute lymphoblastic leukemia
46. The German multicenter trials for treatment of acute lymphoblastic leukemia in adults. The German Adult ALL Study Group
47. The role of chromosome translocations in T cell acute leukemia
48. SLUG, a ces-1-related zinc-finger transcription factor gene with antiapoptotic activity, is a downstream target of the E2A-HLF oncoprotein
49. Hyperdiploid acute lymphoblastic leukemia with 51 to 65 chromosomes: A distinct biological entity with a marked propensity to undergo apoptosis
50. Pre-pre-B acute lymphoblastic leukemia: High frequency of alternatively spliced ALL1-AF4 transcripts and absence of minimal residual disease during complete remission
51. Hematologic malignancies with t(4;11)(q21;q23) - A cytogenetic, morphologic, immunophenotypic and clinical study of 183 cases
52. E2A-Pbx1 induces growth, blocks differentiation, and interacts with other homeodomain proteins regulating normal differentiation
53. Homozygous deletion of the p16/MTS1 gene in pediatric acute lymphoblastic leukemia is associated with unfavorable clinical outcome
54. Clinical significance of TAL1 gene alteration in childhood T-cell acute lymphoblastic leukemia and lymphoma
55. Immunoglobulin gene associated chromosomal translocations in B-cell derived tumors
56. Hematologic malignancies with the t(10;11) (p13;q21) have the same molecular event and a variety of morphologic or immunologic phenotypes
57. p27(KIP1) deletions in childhood acute lymphoblastic leukemia
58. A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia
59. Transforming properties of chimeric TEL-JAK proteins in Ba/F3 cells
60. Outcome and lineage involvement in t(12;21) childhood acute lymphoblastic leukaemia
61. Specification of Drosophila hematopoietic lineage by conserved transcription factors
62. Incidence of TEL-AML1 fusion in children with relapsed acute lymphoblastic leukemia
63. Genes altered by chromosomal translocations in leukemias and lymphomas
64. TEL is a sequence-specific transcriptional repressor
65. Genomic organization of the putative human homeobox proto-oncogene HOX-11 (TCL-3) and its endogenous expression in T cells
66. Immunophenotypic and genotypic features, clinical characteristics, and treatment outcome of adult pro-B acute lymphoblastic leukemia: Results of the German multicenter trials GMALL 03/87 and 04/89
67. TEL-AML1 fusion identifies a subset of children with standard risk acute lymphoblastic leukemia who have an excellent prognosis when treated with therapy that includes a single delayed intensification
68. Acquisition of p16(INK4A) and p15(INK4B) gene abnormalities between initial diagnosis and relapse in children with acute lymphoblastic leukemia
69. Unrelated donor bone marrow transplantation for children and adolescents with Philadelphia-positive acute lymphoblastic leukemia
70. Molecular cytogenetics of childhood hematological malignancies
71. Helix-loop-helix proteins: Regulators of transcription in eukaryotic organisms
72. TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia
73. 6q Deletions in acute lymphoblastic leukemia and non-Hodgkin's lymphomas
74. The C. elegans cell-death specification gene ces-1 encodes a Snail-family zinc-finger protein
75. Transcriptional regulator of programmed cell death encoded by Caenorhabditis elegans gene ces-2
76. The translocations, t(11;19)(q23;p13.1) and t(11;19)(q23;p13.3): A cytogenetic and clinical profile of 53 patients
77. Breakpoints at 11q23 in infant leukemias with the t(11;19)(q23;p13) are clustered
78. Detection and quantification of TEL/AML1 fusion transcripts by polymerase chain reaction in childhood acute lymphoblastic leukemia
79. Identification of new translocations involving TEL/ETV6 in hematological malignancies using FISH and spectral karyotyping
80. Frequent deletion of p16(INk4a)/MTS1 and p15(INK4b)/MTS2 in pediatric acute lymphoblastic leukemia
81. Fusion of TEL, the ETS variant gene 6 (ETV6) to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia
82. Clinical preparation, karyotypic characterization and treatment outcome of childhood acute lymphoblastic leukemia with a near-haploid or hypodiploid < 45 line
83. Near-triploid and near-tetraploid acute lymphoblastic leukemia of childhood
84. Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia with the t(4;11) (q21:q23): A collaborative study of 40 cases
85. Acute lymphoblastic leukemia in children
86. Childhood acute lymphoblastic leukemia with the t(4;11)(q21;q23): An update
87. Acute lymphoblastic leukemia
88. Prognostic importance of structural chromosomal abnormalities in children with hyperdiploid (greater than 50 chromosomes) acute lymphoblastic leukemia
89. Reappraisal of the clinical and biologic significance of myeloid-associated antigen expression in childhood acute lymphoblastic leukemia
90. Significance of commonly used prognostic factors differs for children with T-cell acute lymphocytic leukemia (ALL), as compared to those with B-precursor ALL: A Pediatric Oncology Group (POG) study
91. Second allogeneic marrow transplantation for patients with recurrent leukemia after initial transplant with total-body irradiation-containing regimens
92. Cytogenetics of childhood T-cell leukemia
93. Cytogenetics of pre-B-cell acute lymphoblastic leukemia with emphasis on prognostic implications of the t(1;19)
94. Acute lymphoblastic leukemias with deletion of 11q23 or a novel inversion (11)(p13q23) lack MLL gene rearrangements and have favorable clinical features
95. Heterogeneity of hyperdiploid (51-67) childhood acute lymphoblastic leukemia
96. Hyperdiploid (47-50) acute lymphoblastic leukemia in children
97. Favorable outcome of B-cell acute lymphoblastic leukemia in childhood: A report of three consecutive studies of the BFM group
98. Clinical and biologic features of childhood T-cell leukemia with the t(11;14)
99. Intensive chemotherapy for Philadelphia-chromosome-positive acute lymphoblastic leukaemia
100. The critical role of chromosome translocations in human leukemias
101. Genetic studies of childhood acute lymphoblastic leukemia with emphasis on p16, MLL, and ETV6 gene abnormalities: Results of St Jude Total Therapy Study XII
102. Low frequency of TEL-AML1 in relapsed acute lymphoblastic leukemia supports a favorable prognosis for this genetic subgroup
103. Childhood acute lymphoblastic leukemia with the MLL-ENL fusion and t(11;19)(q23;p13.3) translocation
104. Cytogenetic and molecular defects in the acute lymphoid leukemias
105. TEL gene rearrangement in acute lymphoblastic leukemia: A new genetic marker with prognostic significance
106. Case-control study suggests a favorable impact of TEL rearrangement in patients with B-lineage acute lymphoblastic leukemia treated with antimetabolite-based therapy: A Pediatric Oncology Group study
107. HOX11 expression in pediatric acute lymphoblastic leukemia is associated with T-cell phenotype
108. LIM domain proteins in leukemia and development
109. A Bcr/Abl kinase antagonist for chronic myelogenous leukemia: A promising path for progress emerges
110. Philadelphia chromosome-positive (Ph+) childhood acute lymphoblastic leukemia: Good initial steroid response allows early prediction of a favorable treatment outcome
111. Prognostic significance of the balanced t(1;19) and unbalanced der(19)t(1;19) translocations in acute lymphoblastic leukemia
112. Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukaemia on MRC trial UKALL XA. MRC Adult Leukaemia Working Party
113. TEL-AML1 fusion transcript in relapsed childhood acute lymphoblastic leukemia
114. Mutational analysis of the p15 and p16 genes in acute leukaemias
115. Intensified therapy for infants with acute lymphoblastic leukemia: Results from the Dana-Farber Cancer Institute Consortium
116. Frequent loss of heterozygosity at the TEL gene locus in acute lymphoblastic leukemia of childhood
117. Low incidence of TAL1 gene rearrangements in adult acute lymphoblastic leukemia: A Cancer and Leukemia Group B study (8762)
118. TEL is one of the targets for deletion on 12p in many cases of childhood B-lineage acute lymphoblastic leukemia
119. AF5q31, a newly identified AF4-related gene, is fused to MLL in infant acute lymphoblastic leukemia with ins(5;11)(q31;q13q23)
120. Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood: A Pediatric Oncology Group study
121. Clinical significance of MLL-AF4 fusion transcript expression in the absence of a cytogenetically detectable t(4;11)(q21;q23) chromosomal translocation
122. Clinical significance of Philadelphia chromosome positive pediatric acute lymphoblastic leukemia in the context of contemporary intensive therapies: A report from the Children's Cancer Group
123. Clinical significance of translocation t(1;19) in childhood acute lymphoblastic leukemia in the context of contemporary therapies: A report from the Children's Cancer Group
124. Biology and treatment of childhood T-lineage acute lymphoblastic leukemia
125. Alpha-interferon improves survival and remission duration in P-190BCR-ABL positive adult acute lymphoblastic leukemia
126. The t(14;21)(q11.2;q22) chromosomal translocation associated with T-cell acute lymphoblastic leukemia activates the BHLHB1 gene
127. Trisomy 21 in childhood acute lymphoblastic leukemia: A Pediatric Oncology Group study (8602)
128. Aberrant p15 promoter methylation in adult and childhood acute leukemias of nearly all morphologic subtypes: Potential prognostic implications
129. Deletions of p15 and/or p16 genes as a poor-prognosis factor in adult T-cell leukemia
130. Translocation 11;14 in three children with acute lymphoblastic leukemia of T-cell origin
131. TEL/AML1 positivity in childhood ALL: Average or better prognosis? Czech Paediattic Haematology Working Group